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Small molecules formed during lipid peroxidation can react with the basic groups in proteins
through different mechanisms. Recently, substituted pyridinium moieties were observed
during in vitro incubations of lysine-containing peptides with 2-alkenals. To explore the
dissociation behavior of peptides with pyridinium-derivatized lysine residues, the peptide
ions created through either matrix-assisted laser desorption/ionization or electrospray ioniza-
tion were studied with tandem mass spectrometry. The permanently charged pyridinium ions
fragment primarily through the charge-remote processes. Under high energy collision-induced
dissociation, a number of diagnostic ions were observed that could potentially be used to
identify modified residues in proteins. The origins of these ions were studied using deuterium
exchange and higher-order mass spectrometry experiments using an ion trap instrument.
Rational structures for these ions are proposed. (J Am Soc Mass Spectrom 1999, 10,
613–624) © 1999 American Society for Mass Spectrometry
Anumber of disease states such as cancer [1],arteriosclerosis [2], or diabetes mellitus [3] arecharacterized by increased levels of lipid per-
oxidation. During lipid peroxidation, highly reactive
free radical species are formed. These species, such as
the hydroxyl radical or lipid peroxyl radicals can react
directly with lipids, proteins, or other biomolecules [4,
and references therein]. In addition to these primary
species, a number of secondary products are formed, such
as 2-alkenals [5], 4-hydroxy-alkenals, and malonaldehyde
[6, and references therein]. 4-Hydroxynonenal and malon-
aldehyde adducts have been observed with proteins and
other biomolecules using immunochemical [7, 8] and
mass-spectrometric techniques (MS) [9, 10].
The alkenals are another class of compounds origi-
nating from lipid peroxidation that can also form ad-
ducts with proteins [11–14]. Incubation of proteins with
2-alkenals causes enzyme inhibition and ultimately
inactivation [15] or other substantial changes in protein
structure [12]. The products formed during the reaction
of the e-amino group of lysine and 2-alkenals have been
characterized recently [14]. This reaction leads to the
formation of pyridinium moieties with either 2:1 or 3:2
alkenal to lysine stoichiometry, although some single
Michael adducts are also formed [14]. Additionally,
these modified lysine groups are trypsin insensitive,
leading to missed cleavage sites during proteolytic
digestion [12].
As the presence of modified amino acids cause
changes in protein structure and function, these modi-
fications must be taken into account when attempting to
identify proteins that participate in pathophysiology of
the disease states mentioned above. Mass spectrometry
techniques for peptide sequence determinations are
now widely used in biochemical and proteomic studies
[16–22]. After isolation, enzymatic digestion, and char-
acterization of the peptides released from a protein or
mixture of proteins, the chemical information about the
peptides must be translated into an amino acid se-
quence for identification. Many approaches to these
studies attempt to match experimental data (peptide
molecular weight, enzyme specificity, and sequence
data such as sequence tags) to theoretically generated
information from protein databases [18, 20]. The pres-
ence of posttranslational modifications (glycosylated,
prenylated, phosphorylated, etc. residues), or chemi-
cally modified amino acid residues makes these studies
difficult, as the presence of these species is rarely
accounted for in the databases obtained from DNA
sequences. In these cases, a de novo approach to se-
quencing the modified peptides must be developed.
Mass spectrometry techniques for sequencing pep-
tides often rely on the well-established, proton-medi-
ated fragmentation processes [23]. In the case of perma-
nently charged species, ion fragmentation proceeds
through charge-remote processes [24, 25]. Several
groups have used fixed-charge derivatives (such as
quaternary ammonium, phosphonium, and naphthale-
nesulfonate) to place a permanent charge on either the
amino- or carboxy-terminus of a peptide [26–28], often
simplifying the tandem mass spectrometry spectra by
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forcing ion decomposition through a smaller number of
pathways. Ideally, this strategy leads to a single, unin-
terrupted series of ions [27, 28]. Peptides containing
fixed-charge derivatives at other positions in the pep-
tide chain also fragment through charge-remote pro-
cesses, in many cases leading to incomplete sequence
information for the modified species [29].
In an effort to characterize the damage to proteins
caused during lipid peroxidation, lysine-containing
peptides were modified with trans-2-hexenal. These
peptides were studied using matrix-assisted laser de-
sorption/ionization (MALDI) and electrospray ioniza-
tion (ESI) tandem mass spectrometry. Deuterium ex-
change coupled with the tandem mass spectrometry
experiments was used to characterize the fragmentation
channels in the pyridinium-derivatized lysine. Addi-
tional peptides were studied to explore the fragmenta-
tion of peptides modified at the amino-terminus or on
the imidazole ring in histidine residues. A number of
fragment ions specific to the alkenal-modified amino
acids were observed, and rational structures for these
diagnostic ions are being proposed.
Experimental
N-a-acetylglycyllysyl methyl ester (AcGKOMe) was
obtained from Bachem (King of Prussia, PA). Pro–Phe–
Gly–Lys (PFGK), pGlu–Lys–Trp–Ala–Pro (pGlu–
KWAP), leucine enkephalinamide (YGGFL–NH2), Arg–
Lys–Glu–Val–Tyr (RKEVY), N-a-acetylarginine and
lutenizing releasing hormone (pGlu–His–Trp–Tyr–Ser–
Tyr–Gly–Leu–Arg–Pro–Gly–NH2) (LRH) were obtained
from Sigma (St. Louis, MO). Trans-2-hexenal, deuter-
ated trifluoroacetic acid (dTFA) and the 100.0% atom
D2O used during the exchange studies were obtained
from Aldrich (Milwaukee, WI). All other chemicals
were of laboratory grade.
Peptides were modified by incubation for 24 h in the
presence of a threefold molar excess of freshly distilled
trans-2-hexenal as previously described [14]. The reac-
tion mixtures were lyophilized and the modified pep-
tides were isolated by HPLC on a Perkin-Elmer LC-250
provided with a Whatman Partisil 5-ODS (4.6 3 250
mm, 5 mm particle size) column. Gradient elution was
performed using 0.1% aqueous trifluoroacetic acid
(TFA) and 10% to 60% aqueous acetonitrile over 50 min.
The pyridinium-derivatized AcGKOMe ester was
hydrolyzed by incubating 100 mg of the peptide in 500
mL of 1 M aqueous TFA for 24 h at 60 °C and subse-
quently isolated from the unhydrolyzed peptide by the
reversed-phase HPLC using the described system. The
pyridinium-derivatized AcGKOMe ester was transes-
terified by incubating 100 mg of the peptide in 500 mL of
1 M ethanolic TFA for 24 h at 60 °C. 500 mL of water was
added to the mixture and then lyophilized. The peptide
ethyl ester was isolated from the starting material by
HPLC using the above system.
Mass Spectrometry
Electrospray ionization/ion trap mass spectrometry
was performed using a modified Finnigan ITMS as
described by Van Berkel et al. [30]. Instrument control
was provided by the ICMS software developed by Yates
and Yost [31]. Peptides were dissolved in 50:50 H2O:
ACN and electrosprayed at 1.8 kV from a tapered fused
silica emitter [32]. For the tandem mass spectrometry
experiments, ions were isolated using either single-
ramp resonant ejection [33] or reverse-then-forward ion
isolation [34] techniques. Ions were activated using
resonant excitation at either qz 5 0.2 or 0.3 for 1 to 10
ms at less than 100 mV0–p.
Delayed extraction MALDI-time-of-flight (TOF)
mass spectrometry, post-source decay (PSD), and colli-
sion-induced dissociation (CID) MS/MS were per-
formed using a PerSeptive Biosystems RP-DE instru-
ment operated in the positive ion mode with a-cyano-
4-hydroxy-cinnamic acid (a-CHCA) matrix [35].
Approximately 10 pmol of each peptide were applied to
the stainless steel sample plate and mixed with 1 mL of
matrix solution (saturated a-CHCA in 50:50:0.1 H2O:
ACN:TFA). For the CID MS/MS studies, argon was
used as the collision gas, whereas the pressure in the
source region was 2 3 1026 torr. 16 to 32 laser shots
were acquired for each spectrum, with 12 to 16 individ-
ual spectra stitched together to form each product ion
spectrum. For the MS/MS experiments, a resolution of
60 was used for precursor ion selection.
On-plate deuterium exchange was performed using
a modification of the procedure described by Spengler
et al. [36]. a-CHCA was suspended in 50:50:0.1 D2O:
ACN:dTFA, lyophilized several times, and finally re-
suspended in 50:50:0.1 D2O:ACN:dTFA at 10 mg/mL.
After acquisition of the normal spectra, equal portions
(1 mL) of 50:50:0.1 D2O:ACN:dTFA and the deuterium-
exchanged matrix solution were added to the sample
well (under nitrogen atmosphere), and allowed to dry.
Additional 1 mL aliquots of 50:50:0.1 D2O:ACN:dTFA
were added to ensure that the all of the exchangeable
hydrogens had been exchanged.
Results and Discussion
Crude mixtures of the reaction products formed during
incubation of several model peptides containing lysine
or histidine were analyzed by MALDI-TOF MS. The
molecular weight data for the unmodified and derivat-
ized peptides are shown in Table 1. Arginine residues
were not modified during the incubation, as deter-
mined by other experiments using N-a-acetylarginine
(data not shown). The reaction products were charac-
terized as either the lysine-pyridinium adduct [14], the
histidine Michael adduct [11], or an N-terminal pyri-
dinium adduct as shown in Scheme 1. Prior to other
mass spectrometry experiments, the derivatized pep-
tides were purified using reversed-phase HPLC.
The pyridinium ions are formed via an initial Schiff-
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base condensation between the lysine e-amino group
and an aldehyde, followed by reaction with another
alkenal and subsequent water loss. The resulting dihy-
dropyridine intermediate is oxidized to form the pyri-
dinium cation. Formally, this represents the addition of
two alkenal molecules, with the loss of two water
molecules and two H atoms [14]. An analogous reaction
between two alkenals and the N-terminal amino group
is responsible for the formation of the N-terminal pyri-
dinium moiety. Formation of the Michael adduct be-
tween histidine and an alkenal involves a nucleophilic
attack on C3 of the alkenal, resulting in a mass shift for
the peptide equal to the mass of the alkenal [11].
Dissociation Channels in Pyridinium-
Derivatized AcGKOMe
A representative MALDI-CID product ion spectrum for
AcGKOMe is shown in Figure 1 along with a spectrum
of the unmodified peptide. Formation of the pyri-
dinium-derivatized lysines results in cis–trans isomer-
ism around the double bond (Scheme 1), however, the
fragmentation patterns reported here are identical for
the cis and trans isomers. All of the fragments in the
unmodified peptide and most of the fragments in the
modified were consistent with the scheme proposed by
Biemann and co-workers [17, 24], and are summarized
in Scheme 2. The presence of the quaternary nitrogen in
the pyridinium moiety directs much of the fragmenta-
tion in the modified species, forming the conventional
a-, b-, and y-series fragment ions. Additional evidence
for the charge-remote fragmentation is seen with the v2
fragment ion, formed by the loss of acetaldehyde. Loss
of ketene was also observed [37]. Because of the pres-
ence of the charge-bearing pyridinium moiety, the
b-type ion structure is most consistent with the ox-
azolone structure proposed by Harrison and others [38,
39]. Such a structure arises through the elimination of
methanol from the oximio tautomer of the fixed-charge
derivative. The fragment ions observed in MALDI-CID
and MALDI-PSD of the pyridinium-derivatized
AcGKOMe as well as the free acid and ethyl ester
derivatives are shown in Table 2.
Along with the predicted fragment ions, a number of
other ions specific to the derivatized lysine are also
observed. Most notable is the presence of a peak at m/z
176, which corresponds to the protonated pyridinium
moiety (HPy1). This ion is observed in both the PSD
and high energy CID modes. In studies with model
compounds, Katritzky et al. have observed that the
fragmentation of N-alkyl pyridinium cations progresses
through two pathways, forming either the protonated
pyridinium ion and an olefin or the neutral pyridine
and an alkyl cation [40, 41]. The major dissociation
channel observed with the AcGKOMe peptide pro-
gressed through the first pathway. According to Ka-
tritzky, this pathway proceeds through a loose, proton-
bound complex between the pyridinium moiety and the
olefin corresponding with the lysine alkyl chain [40].
However, a peak at m/z 243 (labeled C1-Py in Figure 1)
was observed, which is consistent with the second
pathway proposed by Katritzky et al. [41].
In the CID experiments, a series of fragment ions at
m/z 202, 216, and 230 is observed. These ions were
assigned as charge-remote fragments (CRF) involving
the pyridinium moiety and elements of the lysine side
chain. Such charge remote fragmentation phenomena
have been studied extensively by Gross and others
Table 1. Results of MALDI-TOF analysis of crude reaction mixtures
Peptide Unmodified m/z Modified m/za Assignment
AcGlomE 260.1 418.2 M 1 Pyridinium
759.5 M 1 Pyridinium crosslink
PFGK 448.5 606.1 M 1 Pyridinium
RKEVY 694.8 853.1 M 1 Pyridinium
pGlu–KWAP 612.6 770.8 M 1 Pyridinium
pGlu–HWSYGLRPG–NH2 1183.3 1281.4 (M 1 H
1) M 1 Michael adduct
YGGFL–NH2 555.7 713.4 M 1 Pyridinium
aUnless otherwise noted, m/z values for the modified peptides are for the singly charged cation.
Scheme 1. Reactions between peptide basic residues and 2-alk-
enals formed as a result of lipid peroxidation.
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[42–44]. A 1,4-elimination is presented as the mecha-
nism for this cleavage, resulting in the formation of two
olefin species and a molecule of H2 [43]. These species
were observed during CID using helium as the collision
gas, but not in the PSD spectra, indicating that high
energy collisional activation is necessary for the forma-
tion of these charge-remote fragments [44]. Another
species formed during the CID experiment is an ion of
Figure 1. MALDI-CID product ion spectra of unmodified Ac–Gly–Lys–OMe (top panel) and
Ac–Gly–Lys–OMe with the hexenal-derived pyridinium lysine moiety (bottom panel). Peptide
nomenclature follow the system described by Biemann and Papayannopoulos [17]. Structures for the
low-mass peaks labeled K are lysine-specific fragmentation ions described by Spengler et al. [36].
Other fragment abbreviations are discussed in the text.
Scheme 2. Dissociation channels observed in hexenal-pyridinium derivatized Ac–Gly–Lys–OMe.
The species marked as charge-remote fragments are not observed in the PSD mode.
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m/z 189, most likely the radical cation resulting from
side-chain cleavage alpha, beta with respect to the
pyridine ring [44].
The peak at C1-91 (m/z 327) was not easily explained.
Product ion spectra from the free acid derivative
(AcGKOH m/z 404) did not contain the peak at m/z 327.
Instead, the y1 fragment (m/z 305) and lysine pyri-
dinium immonium-type ion (LysPyimm; m/z 259) shown
in Scheme 2 were much more intense. After transesteri-
fication to the ethyl ester, the peak at m/z 327 was
increased relative to a peak height from the correspond-
ing y1 fragment ion (m/z 331).
These derivatization experiments suggest that for-
mation of the ion at m/z 327 is dependent on the
functional group attached to the C-terminus of the
peptide. The ion must be formed from the loss of an
alcohol or alkoxy moiety, as the ion is not formed via
dehydration of the free acid derivative. There were no
other major differences observed in the dissociation
channels for the three species. The m/z data for the
different C-terminal derivatives (Table 2) were consis-
tent with the dissociation channels and ion structures
proposed in Scheme 2.
To gain more insight into the dissociation channels
observed with the AcGKOMe peptide, on-plate deute-
rium exchange studies were performed. MALDI-CID
MS/MS studies after deuterium exchange result in
mass shifts for the fragment ions equal to the number of
exchangeable hydrogen atoms present [36]. Results
from the exchange studies using AcGKOMe and
AcGKOH are shown in Table 3. There is no evidence of
hydrogen scrambling in the CRF fragments. However,
in the case of the pyridinium ion (HPy1), there was a
peak at m/z 177 (about 30% of the peak height at m/z
176), corresponding to the mono-deuterated species.
This indicates that the proton abstracted by the pyridine
moiety can come from the peptide backbone (deuteri-
um atoms from the amide group) as well as the lysine
alkyl chain.
Fragmentation of the exchanged C1 precursor ion
(m/z 420) containing two amide deuteriums also results
in the formation of the m/z 327 ion. The m/z 327 ion must
contain at least two nitrogens (the initial e-amino nitro-
gen from the underivatized peptide and one nitrogen
from the peptide backbone), yet no deuterium exchange
is observed. This indicates that some significant rear-
rangement of the peptide backbone is required to form
this ion.
To further investigate the m/z 327 peak, a series of
tandem mass spectrometry experiments were per-
formed using an ion trap instrument. An ESI-MS2
spectrum of AcGKOMe is shown in Figure 2a. Many of
the same fragments observed in the MALDI-MS/MS
experiments—though not the charge-remote fragments
of m/z 189, 202, 216, and 230—were observed in the low
energy ITMS-CAD spectra. A new series of rearrange-
ment ions was observed (most likely due to the multiple
collisions [44]). The most dominant fragment ions were
the previously mentioned pyridinium ion at m/z 176
and the ion at m/z 327.
A series of MSn experiments was performed to probe
the fragmentation channels of the m/z 327 ion. The
Table 2. Results from MALDI-MS/MS experiments performed on the pyridinium-
derivatized AcGKOMe and the free acid or ethyl ester analogs. For the CID experiments,







C1 418.1 418.2 404.0 432.4
b2 386.1 386.4 386.1 386.2
v2 374.0 374.0 360.0 388.2
a2 358.4 358.4 358.0 358.4
C1-91a 327.1 327.3 327.3




CRF 230.2 230.0 230.3
CRF 216.1 216.3 216.3
CRF 202.3 202.2 202.1
y2-Py 201.4 201.4 215.3
CRF 189.2 189.0 189.4
HPy1 176.4 176.5 176.3 176.7
y1-Py 144.4 144.4
b 158.3
Kimm 130.1 130.0 130.3
c1 117.0 117.2 117.5
b1 100.3 100.3 100.6 100.0
Kimm 84.2 84.2 84.1 84.3
aNotation is correct for the methyl ester derivative. The corresponding loss for the free acid and ethyl
ester derivatives are C1-77 and C1-105, respectively.
bIsobaric with lysine specific fragment ions [36].
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results of the MS3 and MS4 experiments are shown in
Figure 2b. From these studies, the dissociation channels
for the AcGKOMe pyridinium ion and putative struc-
tures for the fragment ions are shown in Scheme 3. The
ion at m/z 327 represents a reasonably stable intermedi-
ate, likely formed from the b2 ion through the loss of 59
Da. It appears plausible that the elements of neutral
acetamide (CH3CONH2) are removed through a 1,4
elimination mechanism similar to that proposed by
Gross and co-workers [43]. Further cleavage of the m/z
327 ion is believed to occur between the pyridinium
nitrogen and the aliphatic side chain, thus accounting
for the ions at m/z 152 and 176 (corresponding to the
HPy1 ion), in keeping with the mechanism described
by Katritzky et al. [40, 41]. Another fragmentation or a
rapid (on the time scale of the ion trap collisional
activation process [45]) series of fragmentations result
in the formation of an ion of m/z 257, believed to contain
the cyano group, from the oxazalone (m/z 327) moiety
through the elimination of the elements of methyl-
enepropiolactone (C3H2O2; 70 Da). Subsequent activa-
tion of this species results in the formation of the HPy1
ion. Results from ESI-MS2 studies performed in a D2O:
ACN solvent system were consistent with the results
presented for the MALDI-CID MS/MS studies (data not
shown).
AcGKOMe Pyridinium Crosslink
Tandem mass spectrometry studies with the pyri-
dinium crosslink formed by the reaction of a lysine–
dihydropyridine with a lysine Schiff base indicate that
the fragmentation behavior is very similar to that of the
pyridinium-derivatized lysine moieties. Tandem mass
spectrometry studies with the ESI-ITMS system were
performed on the pyridinium crosslink, and represen-
tative spectra from these experiments are shown in
Figure 3. The fragmentation pathways leading to the
formation of these ions are shown in Scheme 4. The first
major fragment ion from the pyridinium crosslink (pan-
el a) at m/z 474 represents a loss of the second peptide
and two methylene units from the third alkenal. MS3
studies performed on this ion resulted in the loss of a
propylene group, resulting in a methyl group on the 5
position of the pyridinium ring (m/z 432) (data not
shown).
The same ion (m/z 474) was observed in the MS2
spectra of the intact pyridinium crosslink. The results of
an MS3 experiment performed on the m/z 432 ion (panel
b) indicate that the ion chemistry and dissociation
channels for this ion are very similar to those of the
pyridinium-derivatized AcGKOMe (m/z 418) species
shown in Scheme 2. The decomposition progresses
through species of m/z 341 and m/z 271 before forming
the m/z 190 species. These species are analogous to the
m/z 327, m/z 257, and m/z 176 species described above.
Similar results were obtained with the MALDI-TOF
tandem mass spectrometry experiments.
Other peptides containing the pyridinium-derivat-
ized lysine moiety were also studied using MALDI-CID
MS/MS. Spectra for the modified and unmodified
RKEVY are shown in Figure 4. Many of the fragmenta-
tion pathways for the modified and unmodified species
are similar, although the b-type ions are less prevalent
in the modified species. The presence of the quaternary
nitrogen in the modified peptide strongly directs frag-
mentation, resulting in mainly the formation of a-type
ions, as discussed by Johnson et al. [24], although no
Table 3. Results of the on-plate deuterium exchange studies. After analysis by MALDI-CID MS/MS, the sample spots were
exchanged with deuterium as described in the Experimental section and reanalyzed
Fragment Hexenal–Py–OH Exchanged D Hexenal–Py–OMe Exchanged D
C1 404.0 407.2 3 418.2 420.1 2
b2 386 388 2 386.4 388.2 2
v2 360.0 363 2 374.0 376.1 2
a2 358.0 360 2 358.4 360.5 2
C1-91a 327.3 327 0
y1 305.1 308 3 319.1 320 1
LysPyimm 259.2 260 1 259.5 260 1
257.2 257 0
242.9 245.2 3
CRF 230.0 230.3 0 230.2 230.2 0
CRF 216.3 216.8 0 216.1 216.1 0
CRF 202.2 202.2 0 202.3 202.3 0
y2-Py 201.4 203.4 2
CRF 189.0 189.2 0 189.2 189.2 0
Py–H 176.3 176.7 0 176.5 176.5 0
y1-Py
b b 144.1 146.5 2
Kimm 130.0 132.1 2 130.1 132.1 2
c1 117.2 119.5 2 117.0 119.2 2
b1 100.6 101.3 1 100.3 101.2 1
Kimm 84.1 85.1 1 84.2 85.2 1
aNotation is correct for the methyl ester derivative. The corresponding loss for the free acid derivatives is C1-77.
bIsobaric with lysine specific fragment ions [36].
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d-type ions were observed. The pyridinium-derivatized
lysine specific ions (HPy1 and charge-remote frag-
ments) are again observed in the modified peptide,
whereas other, charge-directed dissociation channels
predominate. In either the PSD or CID modes, loss of
ammonia is observed from the a- and b-type fragment
ions from both the modified and unmodified species.
Two other peptides, Pro–Phe–Gly–Lys and pGlu–Lys–
Trp–Ala–Pro, had similar charge-directed dissociation
channels, indicating that the results described here have
some predictive value for other peptides containing
pyridinium-derivatized lysines.
Modifications to Histidine Residues
A MALDI-CID product ion spectrum of a peptide
containing a histidine residue modified with trans-2-
hexenal is shown in Figure 5. The histidine-type Mi-
chael adduct-containing peptides are observed as pro-
tonated species by MALDI, and as such, the
Figure 2. (a) ESI-ITMS MS2 spectrum of Ac–Gly–Lys–OMe obtained using the modified ITMS
system. Ion activation was performed at qz 5 0.2 for 5 ms prior to data aquisition. (b) Product ion
spectra obtained from MSn studies of Ac–Gly–Lys–OMe. Ions were isolated using single-ramp
resonant ejection techniques after each fragmentation step.
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fragmentation pathways for modified peptides are
more similar to the unmodified species than was the
case with the pyridinium-derivatized lysine residues. In
this study, a histidine-type Michael adduct immonium
ion at m/z 208 and a series of N-terminal fragment ions
were observed. Analogous histidine immonium and
sequence ions containing the modified histidine residues
were observed during a direct infusion-MS2 experiment
Scheme 3. Major dissociation channels observed during ESI-tandem mass spectrometry experiments
with pyridinium-derivatized Ac–Gly–Lys–OMe.
Figure 3. ESI-MSn spectra of Ac–Gly–Lys–OMe pyridinium crosslink species. Top panel: MS2
spectrum of pyridinium crosslink species. Bottom panel: MS3 spectrum of pyridinium crosslink
species. The parent ion (759.5 m/z) was isolated using a reverse-then-forward isolation step followed
by ion activation at qz 5 0.3 for 10 ms prior to isolation of the 432 m/z daughter ion. Activation of the
432 m/z ion was performed at qz 5 0.2 for 5 ms prior to data aquisition.
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performed on a tryptic digest of 4-hydroxynonenal-mod-
ified myoglobin [10]. In the unmodified peptide, there are
a number of C-terminal fragments, resulting from the
proton residing most probably on either the proline or
arginine residue. In the case of the modified peptide, only
one C-terminal fragment ion (y2) was observed, indicating
that the modified histidine is the most likely site of
protonation, at least for the smaller a- and b-series frag-
ments.
Modifications at the N-Terminus
A model peptide containing an unmodified amino-
terminus was also reacted with trans-2-hexenal.
MALDI-TOF analysis of the crude peptide mixture
indicated that the major product after modification was
also a pyridinium ion (addition of two alkenals, with
the loss of two water molecules and two H atoms).
Figure 6 shows the MALDI-CID product ion spectra for
modified and unmodified YGGFL–NH2. In the unmod-
ified peptide, the higher a- and b-series ions are ob-
served, along with the y-NH3 fragments. Derivatization
of the N-terminus results in a drastic change in the
fragmentation pattern, forming almost entirely the a-
and b-series ions. The HPy1 ion (m/z 176) and an ion
thought to form from the HPy1 via loss of ethylene (m/z
148) are also observed.
The primary motivation for these studies was to
Scheme 4. Major dissociation channels observed during ESI-tandem mass spectrometry experiments
with Ac–Gly–Lys–OMe pyridinium crosslink species.
Figure 4. MALDI-CID product ion spectra of unmodified (top panel) and modified (bottom panel)
Arg–Lys–Glu–Val–Tyr.
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explore the ion chemistry of modified lysine groups
such as would be observed during the studies of intact
proteins. However, Kautiainen has shown that alkenals
formed during lipid peroxidation will react with the
N-terminal valine in hemoglobin to form either Schiff
bases or Michael adducts [46]. Under native conditions,
the protein N-terminus would be expected to play a
very minor role in protein modifications. For example,
Figure 6. MALDI-CID product ion spectra of unmodified (top panel) and modified (bottom panel)
Tyr–Gly–Gly–Phe–Leu–NH2. The ion at m/z 148 is consistent with the loss of ethylene from the HPy
1
ion.
Figure 5. MALDI-CID product ion spectra of unmodified (top panel) and modified (bottom panel)
pGlu–His–Trp–Ser–Tyr–Gly–Leu–Arg–Pro–Gly–NH2. The ion marked Himm
* represents the immo-
nium ion for the histidine–hexenal Michael adduct.
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in the case of equine myoglobin, there are 19 lysine and
11 histidine residues, and only one N-terminus. In
multi-subunit proteins, or in cases where the protein
N-terminus is involved in structural interactions, the
N-terminal pyridinium formation could play a larger
role in the overall structure and function of such pro-
teins.
Conclusions
Formation of the lysine-pyridinium species results in
the placement of a fixed, positive charge on the e-amino
group. The presence of the pyridinium cation causes
changes in the dissociation channels for the modified
peptides, giving rise to a number of species-specific,
charge-mediated, and charge-remote fragments. The
ion chemistry of the modified peptides has been ex-
plored using deuterium exchange, MALDI-TOF CID
MS/MS and electrospray tandem mass spectrometry.
Tandem mass spectra of the derivatized peptides
contained fragment ions with derivatized lysine resi-
due, indicating that the pyridinium ion was directing
the charge. A number of low-mass fragments were also
observed during PSD, high-energy CID, and low-en-
ergy collisionally activated dissociation tandem exper-
iments in the ion trap. These ions are formed from the
decomposition of pyridinium-derivatized lysine spe-
cies. One of the most prevalent ions observed here is
formation of the pyridinium cation containing the ly-
sine e-amino group and the elements of the two alk-
enals. In the high energy CID studies, a number of
charge-remote fragments were observed containing the
pyridinium ring and portions of the lysine alkyl chain.
Many of the ions observed during the low energy
collisional studies were diagnostic, but there was also a
number of rearrangement ions with little structural
value.
The presence of these low-mass fragment ions in the
tandem mass spectrometry experiment is indicative of
the presence of a modified histidine or lysine. From the
mass of the fragment ions, the identity of the alkenal(s)
involved in modification can also be determined. As the
modified species are permanently charged in the case of
the lysine pyridinium derivative, or with favored pro-
tonation sites in the case of the histidine derivative,
peptide fragmentation will be directed by these species,
ideally forming a series of sequence-specific ions that
can be used to generate sequence tags for the database
searches. A further constraint would be that a histidine
or lysine must be present in the unmodified peptide.
This strategy could be of assistance in the identification
of modified proteins involved in lipid-peroxidation
related processes.
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